Share price: 108.00p

AGM STATEMENT

23rd May 2006

At the Annual General Meeting of Cello Group plc to be held today, Kevin Steeds, Chairman, will make the following statement:

‘Since the announcement of our preliminary results in March, the Group has continued to make good progress, with results for the first quarter comfortably ahead of budget. Overall trading for the financial year remains in line with expectations with revenue visibility across all of our businesses continuing to be strong.

‘Our market research platform has enjoyed a very strong start to the year reflecting the investments in staff and product offering made last year and is showing excellent organic growth.

‘We are committed to our strategy of building a research and data led consulting Group around our three platforms; planning & research, brand consulting and response. We are focused on developing businesses with secure earnings based on

the intellectual capital of high quality and experienced professionals providing services in growing areas of customer demand.

‘We continue to invest in our existing portfolio of companies to accelerate their organic growth, including several new digital and on line initiatives. In addition we are appraising a small number of exciting new opportunities in all areas of our operations that will further develop our capabilities and add shareholder value.’

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150